Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.
Schroth W, Winter S, Büttner F, Goletz S, Faißt S, Brinkmann F, Saladores P, Heidemann E, Ott G, Gerteis A, Alscher MD, Dippon J, Schwab M, Brauch H, Fritz P. Schroth W, et al. Among authors: heidemann e. Breast Cancer Res Treat. 2016 Jan;155(1):85-97. doi: 10.1007/s10549-015-3651-5. Epub 2015 Dec 9. Breast Cancer Res Treat. 2016. PMID: 26650824
Clinical impacts of histological subtyping primary breast cancer.
Fritz P, Klenk S, Goletz S, Gerteis A, Simon W, Brinkmann F, Heidemann E, Lütttgen E, Ott G, Alscher MD, Schwab M, Dippon J. Fritz P, et al. Among authors: heidemann e. Anticancer Res. 2010 Dec;30(12):5137-44. Anticancer Res. 2010. PMID: 21187502
Tubular breast cancer. A retrospective study.
Fritz P, Bendrat K, Sonnenberg M, Trautmann C, Ott G, Heidemann E, Brinkmann F, Faisst S, Gerteis A, Brauch H, Schwab M, Lindner C, Friedrichs K, Alscher MD, Dippon J, Niendorf A. Fritz P, et al. Among authors: heidemann e. Anticancer Res. 2014 Jul;34(7):3647-56. Anticancer Res. 2014. PMID: 24982382
[Symptom-oriented follow-up of early breast cancer compared to intensive surveillance. Results of a prospective multicentre study: update and 10-year overall survival].
Bornhak S, Heidemann E, Meisner C, Herschlein HJ, Simon W, Merkle E, Schmidt B, Metzger H, Rössle S, Brinkmann F. Bornhak S, et al. Among authors: heidemann e. Dtsch Med Wochenschr. 2012 Oct;137(42):2142-8. doi: 10.1055/s-0032-1327219. Epub 2012 Oct 10. Dtsch Med Wochenschr. 2012. PMID: 23055354 Clinical Trial. German.
Symptom-oriented follow-up of early breast cancer is not inferior to conventional control. Results of a prospective multicentre study.
Bornhak S, Heidemann E, Herschlein HJ, Simon W, Merkle E, Widmaier G, Ernst R, Greulich M, Bittner R, Kieninger G, Merkle P, Strosche H, Karg C, Wellhaeusser U, Aulitzky W, Schmidt B, Metzger H, Hahn M, Stauch A, Meisner C, Selbmann HK, Regelmann C, Brinkmann F. Bornhak S, et al. Among authors: heidemann e. Onkologie. 2007 Sep;30(8-9):443-9. doi: 10.1159/000105257. Epub 2007 Sep 7. Onkologie. 2007. PMID: 17848816
Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis.
Knop S, Engelhardt M, Liebisch P, Meisner C, Holler E, Metzner B, Peest D, Kaufmann M, Bunjes D, Straka C, Fischer T, Sezer O, Hentrich M, Ostermann H, Bassermann F, Hess G, Hertenstein B, Freund M, Kropff M, Schmidt CA, Wolf HH, Jung W, Frickhofen N, Mielke S, Bargou RC, Maschmeyer G, Svaldi M, Langer CH, Gramatzki M, Hebart H, Kanz L, Einsele H; Deutsche Studiengruppe Multiples Myelom. Knop S, et al. Leukemia. 2019 Nov;33(11):2710-2719. doi: 10.1038/s41375-019-0537-2. Epub 2019 Aug 28. Leukemia. 2019. PMID: 31462732 Clinical Trial.
101 results